Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014.Boston Globe via Getty Imageshide caption
A multi-million dollar effort to produce a test to guide treatment for a potentially lethal skin cancer recently fell apart after the scientific investigator discovered that the commercial antibodies he was using were unreliable.
Cultura RM Exclusive/Peter Mulle/Getty Images
Marlene Simpson of Sacramento, Calif., wears compression bandages daily to help reduce the swelling in her legs. She is getting fitted for compression bandages for her arms to prevent swelling there.
Bob Topmiller, chief of toxicology at the Hamilton County Coroner's Office, holds a small vial containing carfentanil extracted from a sample of blood.
Jake Harper/Side Effects Public Media
Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics new headquarters in Cambridge, Mass., in 2014.
Boston Globe via Getty Images
Dr. Lars Aanning, seen at his home outside Yankton, S.D., said he lied to protect a colleague in a malpractice case. Now, Aanning is a patient safety advocate.
Jay Pickthorn/AP for ProPublica
Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector.